Prothrombotic fibrin clot properties are associated with post-discharge venous thromboembolism in acutely ill medical patients.


Journal

Thrombosis research
ISSN: 1879-2472
Titre abrégé: Thromb Res
Pays: United States
ID NLM: 0326377

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 15 02 2019
revised: 13 06 2019
accepted: 17 08 2019
pubmed: 4 9 2019
medline: 28 4 2020
entrez: 4 9 2019
Statut: ppublish

Résumé

Reduced clot permeability and lysability have been reported in patients who experienced venous thromboembolism (VTE) following lower limb injury despite pharmacological thromboprophylaxis. We hypothesized that similarly altered fibrin clot properties characterize patients with post-discharge VTE despite thromboprophylaxis during prior hospitalization due to acute medical illnesses. In a case-control study, we assessed 48 patients who developed VTE within 4 weeks post-discharge despite pharmacological thromboprophylaxis during hospitalization (the thromboprophylaxis group) and three age- and sex-matched control groups (n = 48 each): (1) patients who developed VTE following hospitalization without pharmacological thromboprophylaxis (the no-thromboprophylaxis group), (2) patients with unprovoked VTE and (3) individuals without history of VTE (the no-VTE group). Blood samples were obtained following ≥3 months of anticoagulation in VTE patients. Fibrin clot properties, thrombin generation and fibrinolysis activators and inhibitors were assessed. Compared with the no-VTE group, the thromboprophylaxis group formed denser fibrin networks reflected by lower clot permeability (K Unfavorably altered plasma clot properties and increased thrombin generation characterize medical patients with post-discharge VTE despite receiving pharmacological thromboprophylaxis during hospitalization for acute conditions.

Identifiants

pubmed: 31479942
pii: S0049-3848(19)30340-8
doi: 10.1016/j.thromres.2019.08.010
pii:
doi:

Substances chimiques

Anticoagulants 0
Fibrin 9001-31-4
Thrombin EC 3.4.21.5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

141-149

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Mariusz Wójcik (M)

Clinical Department of Cardiology, Clinical Hospital No. 2 in Rzeszów, Rzeszów, Poland.

Lech Zaręba (L)

Faculty of Mathematics and Natural Sciences, University of Rzeszów, Rzeszów, Poland.

Anetta Undas (A)

Krakow Center for Medical Research and Technology, John Paul II Hospital, Kraków, Poland; Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland. Electronic address: mmundas@cyf-kr.edu.pl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH